News By Tag * Diabetes * Byetta * Drug * Therapy * 2011-2020 * Mechanism * Patient * Inhibitors * Globaldata * Oral * More Tags... Industry News News By Place Country(s) Industry News
|  Byetta (Type 2 Diabetes) - Analysis and Forecasts to 2020 - New Market ReportNew Pharmaceuticals research report from GlobalData is now available from Fast Market Research
By: Fast Market Research, Inc. ------------------------------------------------------------ Full Report Details at - http://www.fastmr.com/ ------------------------------------------------------------ Scope * Therapy area profile including patient population for the US, EU5 and Japan (seven major markets) * Analysis and review of Byetta including historical sales data * Qualitative and quantitative assessment of market space * Analysis of the trends, drivers and restraints shaping and defining the markets * In-depth analysis of Byetta including efficacy, safety, pricing, competition and other details which influence its sales potential * Detailed sales forecast for 2005-2020 for Byetta in the US, EU5 and Japan Reasons to buy * Understand and capitalize by identifying products that are most likely to ensure a robust return * Stay ahead of competition by understanding the changing competitive landscape * Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential * Make more informed business decisions from insightful and in-depth analysis of the drug's performance * Examine the historical sales performance of a drug in seven major markets * Obtain sales forecast for currently marketed/pipeline drug for 2011-2020 for all seven major markets Partial Table of Contents: 1 Table of Contents 1 Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Introduction 2.1 Diabetes 2.2 Epidemiology 2.2.1 Prevalence 2.2.2 Mortality 2.3 Etiology and Risk Factors 2.3.1 Obesity 2.3.2 Sedentary Lifestyle 2.3.3 Family History and Genetics 2.3.4 Ethnicity 2.3.5 Old Age 2.4 Economic Impact of Diabetes 2.5 GlobalData Report Guidance 3 Type 2 Diabetes: Market Characterization 3.1 Type 2 Diabetes Market 3.2 Type 2 Diabetes Market Forecasts 3.3 Type 2 Diabetes Market: Drivers and Restraints 3.3.1 Drivers 3.3.2 Restraints 4 Classification of Diabetes 4.1 Types of Diabetes 4.1.1 Type 1 Diabetes 4.1.2 Type 2 Diabetes 4.1.3 Gestational Diabetes 4.2 Diabetes Complications 4.2.1 Cardiovascular Disease 4.2.2 Nephropathy 4.2.3 Neuropathy 4.2.4 Amputation 4.2.5 Retinopathy 5 Evolution of Anti-Diabetic Treatments 6 Medications 6.1 Insulin 6.2 Oral Medications 6.2.1 Sulfonylureas (SUR) 6.2.2 Biguanides (BGDs) 6.2.3 Alpha-Glucosidase Inhibitors (AGI) 6.2.4 Meglitinides 6.2.5 Thiozolidinediones (TZDs) 6.2.6 Dipeptidyl Peptidase IV (DPP- 4) Inhibitors 6.2.7 Oral Combination Therapy 6.3 Other Injectionable Medications 6.3.1 Pramlintide 6.3.2 Exenatide 6.4 Market Share as per Classes in Type 2 Diabetes 7 Byetta 7.1 Introduction 7.2 Mechanism of Action 7.3 Clinical Studies 7.3.1 Monotherapy 7.3.2 Combination Therapy 7.4 Approval History of Byetta 7.5 Factors Affecting Sales of Byetta 7.5.1 First in a New Class of Medicines 7.5.2 Association of Byetta with Weight Loss among Patients 7.5.3 Approval as a Monotherapy for First Line Treatment in the US 7.5.4 Byetta Becoming the Fourth Most Prescribed Drug in the US 7.5.5 Reporting of Acute Pancreatitis 7.5.6 Competition from Victoza and Januvia 7.5.7 Change in Labeling of Byetta 7.6 Drug Evaluation 7.6.1 Drug Risk Benefit Score 7.6.2 Intensity of Competition 7.7 Sales Forecasts 7.7.1 Target Patient Pool for Byetta 7.7.2 Dosing 7.7.3 Market Penetration 7.7.4 Annual Cost of Therapy 7.7.5 Sales Projections of Byetta 8 Diabetes Market: Appendix 8.1 Market Definitions 8.2 List of Abberiviations 8.3 Research Methodology 8.3.1 Coverage 8.3.2 Secondary Research 8.3.3 Forecasting 8.3.4 Number of Patients Approved to Take the Drug 8.3.5 Net Penetration of Drug 8.3.6 Net Annual Dosing 8.3.7 Annual Cost of Therapy 8.4 Drug Sales Estimates Model 8.5 Contact Us 8.6 Disclaimer 8.7 Sources List of Tables 1.1 List of Tables Table 1: Diabetes, World, Prevalence Estimates for the age group 20-79 years (million), 2000-2030 Table 2: Diabetes, Top 10 Countries, by Prevalence (million), 2010 and 2030 Table 3: Diabetes, Top 10 Countries, Highest Health Expenditures ($bn), 2010 Table 4: Type 2 Diabetes, World, Major Marketed Drugs, 2010 Table 5: Type 2 Diabetes, World, Major Pipeline Products in Phase III Table 6: Diabetes, Worldwide, Prevalence Estimates, 2010 and 2030 Table 7: Overweight*, Global, Prevalence Estimates in Males Aged 15 and above (%), 2005 Table 8: Diabetes Drugs Evolution Table 9: Results of 24-Week Placebo Controlled Trial of Byetta as Monotherapy Table 10: Results of 30-Week Placebo Controlled Trials of Byetta Used in Combination Therapy with Oral Anti-diabetic Agents Table 11: Results of 16-Week Placebo Controlled Trial of Byetta Used in Combination Therapy with Oral Anti-diabetic Agents Table 12: Approval of Byetta by Indication Table 13: Drug Risk Benefit Score of Byetta Table 14: Annual Cost of Therapy of Byetta, 2011 Table 15: Byetta, Type 2 Diabetes, Global, Sales Estimates ($m), 2005-2010 Table 16: Byetta, Type 2 Diabetes, Global, Sales Forecasts ($m), 2011-2020 Table 17: Byetta, Type 2 Diabetes, The US, Sales Estimates ($m), 2005-2010 Table 18: Byetta, Type 2 Diabetes, The US, Sales Forecasts ($m), 2011-2020 Table 19: Byetta, Type 2 Diabetes, The UK, Sales Estimates ($m), 2007-2010 Table 20: Byetta, Type 2 Diabetes, The UK, Sales Forecasts ($m), 2011-2020 Full Table of Contents is available at: -- http://www.fastmr.com/ About GlobalData GlobalData is a leading provider of global business intelligence including market, competitor, product and customer information. It provides in-depth research, analysis, data and forecasts through a range of interactive online databases, reports and management briefings. GlobalData has a large team of experienced research and analysis, consulting, and marketing experts. It has a global presence, including key offices in the US, Europe and Asia. The group has over 50 years of experience of delivering market intelligence data and analysis and a highly experienced senior management team. View more research from GlobalData at http://www.fastmr.com/ # # # Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available. End
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||
Account Phone Number